Stockreport

Novartis Raises Sales Outlook for Mid-Term, Acquires Kate Therapeutics [Yahoo! Finance]

Novartis AG  (NVS) 
Last novartis ag earnings: 4/28 01:00 am Check Earnings Report
US:NYSE Investor Relations: novartis.com/investors
PDF growth rate (CAGR) of 6% during 2023-2028 compared with the previous estimate of 5%. The rise in guidance was due to the strong momentum of NVS' key drugs and its upco [Read more]